Typical features of hepatic steatosis and NAFLD may include elevated TAG and fasting plasma glucose, increased or normal alanine transaminase (ALT), and low HDL cholesterol and can lead to insulin resistance (IR), obesity, and type 2 diabetes mellitus (T2DM) (Yki‐Jarvinen, 2014). The gene discussed is GPT; the disease is fatty liver disease.